PATH is the leader in global health innovation, relentlessly focused on accelerating innovation and bringing it to a global scale. Innovation is woven into every fiber of our organization. It’s how we envision, how we ideate, and how we make choices. It’s also how we collaborate with partners, how we move technologies to scale, and how we work on the ground.
Innovation is how we equip vulnerable global communities with the tools they need to secure a healthy future.
Devise and test solutions over and over
Designing a solution that makes human milk banking safer for all infants
Breast milk is critical to helping infants get a healthy start on life, providing babies with vital antibodies, nutrients, and vitamins. Human milk banks play a valuable role by providing breast milk to vulnerable infants whose mothers are unable to nurse. Low-resourced or rural milk banks in neonatal wards, however, face the challenge of needing to safely pasteurize and test donated breast milk. This is exactly where PATH stepped in. To get safe breast milk to the world’s most vulnerable, PATH worked with its partner, the University of Washington, to develop and test a simple, affordable pasteurization tool using mobile technology to monitor and track the pasteurization process. With a simple solution that uses common tools like a phone, a glass jar, and a water bath, PATH is helping to ensure more babies get a healthy start to life.
Navigate Hurdles to Acceptance and Use
Clearing a pathway for healthier, nourished lives
When PATH received a patent donation for a process that infused micronutrients into rice, we knew it held the potential to improve the health of millions of people, especially children. Delivering a product that meets the nutritional needs of countries across Africa and Asia requires ingenuity and agility, since needs and policies vary greatly from one country to the next. This is where PATH excels.
In Brazil, PATH determined the most effective route for distribution was to take the fortified rice, or Ultra Rice®, directly to the general public, instead of relying on traditional food support programs. PATH licensed the technology to the country’s top rice millers free of charge and partnered with one of Brazil’s largest retailers to get Ultra Rice® onto store shelves. We engaged the Federal University of Viçosa to create a quality assurance system, ensuring high standards for producers. The final challenge? Build confidence among consumers that this unknown product could live up to the promise of improving family health. We designed an innovative social marketing campaign with some of the country’s most respected leaders, celebrities, and sports figures to introduce “Arroz Vitaminado” into homes. To date, the program has reached more than 2.5 million people.
Ultra Rice is a registered trademark of Bon Dente International, Inc., in the United States.
Support Countries And Communities In Adopting Solutions
Supporting Zambia in malaria elimination
Long before Zambia made a declaration to eliminate malaria within its borders, PATH was working on the ground as a committed partner. Since 2005, we’ve worked side-by-side with the National Malaria Control Center, clinics, and community health workers to fight malaria from every angle. Today, communities have taken full ownership of the solutions we helped develop. They’re using rapid diagnostic tests and mobile phones to identify and track cases of malaria. Teams of health workers are being mobilized to test and treat in the remotest places. Communities are building surveillance systems to stop outbreaks before they start. These strategies have contributed to a 55 percent reduction in child deaths between 2001 and 2014, and are helping to chart a course for how malaria can be eliminated once and for all.
Scale Massively To Meet Global Needs
Expanding access to a much-needed vaccine for millions of children
Japanese encephalitis was devastating millions of people in Southeast Asia and the Western Pacific. Nicknamed “brain fever,” Japanese encephalitis begins like the flu, then progresses to a brain infection. It is fatal in nearly 30 percent of its victims and leaves thousands more with permanent brain injuries. PATH led the charge to identify and expand access to a vaccine.
In China, we found a single-dose vaccine that was broadly used within the country, but largely unknown elsewhere. To make it available to the many more who needed it, PATH helped the vaccine producer meet international standards and design a new manufacturing facility for large-scale production. We also negotiated a special public-sector price for the vaccine, ensuring it would be affordable to the countries that most need it. In 2013, the World Health Organization gave its critical stamp of approval to the Japanese encephalitis vaccine, paving the way for use at massive scale. In April 2015, Laos launched a nationwide campaign to vaccinate 1.5 million children. With the addition of Laos, PATH has helped expand the reach of the vaccine to more than 220 million children across Southeast Asia and the Western Pacific.